Ir para o conteúdo
VuFind
  • A sua conta
  • Sair
  • Entrar
  • Idioma
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português (Brasil)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
Avançada
  • Hydroxychloroquine treatment d...
  • Exemplares
  • Citar
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
    • Exportar para BibTeX
    • Exportar para RIS
  • Adic. favoritos
A carregar...

Código QR

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Rheumatol
Main Authors: Rentsch, Christopher T, DeVito, Nicholas J, MacKenna, Brian, Morton, Caroline E, Bhaskaran, Krishnan, Brown, Jeremy P, Schultze, Anna, Hulme, William J, Croker, Richard, Walker, Alex J, Williamson, Elizabeth J, Bates, Chris, Bacon, Seb, Mehrkar, Amir, Curtis, Helen J, Evans, David, Wing, Kevin, Inglesby, Peter, Mathur, Rohini, Drysdale, Henry, Wong, Angel Y S, McDonald, Helen I, Cockburn, Jonathan, Forbes, Harriet, Parry, John, Hester, Frank, Harper, Sam, Smeeth, Liam, Douglas, Ian J, Dixon, William G, Evans, Stephen J W, Tomlinson, Laurie, Goldacre, Ben
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd. 2021
Assuntos:
Correspondence
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7906669/
https://ncbi.nlm.nih.gov/pubmed/33655224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(21)00030-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
  • Exemplares
  • Descrição
  • Comentários
  • Previsualização
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
    Por: Schultze, Anna, et al.
    Publicado em: (2020)
  • Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts
    Por: Wong, Angel YS, et al.
    Publicado em: (2021)
  • Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform
    Por: Rentsch, Christopher T, et al.
    Publicado em: (2020)
  • OpenSAFELY: factors associated with COVID-19 death in 17 million patients
    Por: Williamson, Elizabeth J, et al.
    Publicado em: (2020)
  • Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England
    Por: Forbes, Harriet, et al.
    Publicado em: (2021)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs
A carregar...